Pahwa Rajesh, Wilkinson Steven B, Overman John, Lyons Kelly E
Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Stereotact Funct Neurosurg. 2005;83(2-3):80-3. doi: 10.1159/000086866. Epub 2005 Jul 6.
Younger age and a response to a supra-threshold levodopa challenge have been reported to predict a favorable response to bilateral subthalamic nucleus (STN) stimulation.
To identify and evaluate clinical factors which predict a positive outcome after bilateral STN stimulation in patients with Parkinson's disease, using each patient's typical doses of antiparkinsonian medication rather than a supra-threshold levodopa challenge.
Forty-five Parkinson's disease patients who underwent bilateral STN implantation were included in the study. There were 33 men and 12 women. Mean age and disease duration were 59.4 and 12.7 years, respectively. All patients underwent Unified Parkinson Disease Rating Scale (UPDRS) evaluations in the medication off and on states at baseline and postsurgically with stimulation on at 3, 6 and 12 months. The percentage improvement in UPDRS motor scores at baseline (medication off vs. on) was compared with the percentage improvement after stimulation optimization (baseline medication off vs. follow-up medication off/stimulation on).
The preoperative percentage improvement in UPDRS motor scores with antiparkinsonian medications was predictive of the postoperative percentage improvement in the UPDRS motor scores in the medication off/stimulation on state (r = 0.53, p < 0.001). However, preoperative UPDRS motor scores in the medication on state were more strongly correlated with the postsurgical effect of stimulation (r = 0.64, p < 0.001). The postoperative improvement in UPDRS motor scores with stimulation did not correlate with age, disease duration or time to programming optimization.
The preoperative percentage improvement in UPDRS motor scores with antiparkinsonian medications and UPDRS motor score in the medication on state at baseline are the strongest clinical predictors of responsiveness to bilateral STN stimulation.
据报道,较年轻的年龄以及对超阈值左旋多巴激发试验的反应可预测对双侧丘脑底核(STN)刺激的良好反应。
使用每位患者的典型抗帕金森病药物剂量而非超阈值左旋多巴激发试验,来识别和评估预测帕金森病患者双侧STN刺激后阳性结果的临床因素。
本研究纳入了45例接受双侧STN植入的帕金森病患者。其中男性33例,女性12例。平均年龄和病程分别为59.4岁和12.7年。所有患者在基线时以及术后3、6和12个月刺激开启状态下,于服药和未服药状态接受统一帕金森病评定量表(UPDRS)评估。比较基线时(未服药与服药)UPDRS运动评分的改善百分比与刺激优化后(基线未服药与随访未服药/刺激开启)的改善百分比。
术前使用抗帕金森病药物时UPDRS运动评分的改善百分比可预测术后未服药/刺激开启状态下UPDRS运动评分的改善百分比(r = 0.53,p < 0.001)。然而,术前服药状态下的UPDRS运动评分与术后刺激效果的相关性更强(r = 0.64,p < 0.001)。刺激后UPDRS运动评分的术后改善与年龄、病程或编程优化时间无关。
术前使用抗帕金森病药物时UPDRS运动评分的改善百分比以及基线时服药状态下的UPDRS运动评分是双侧STN刺激反应性最强的临床预测指标。